Adam Hill

Medicine & Life Sciences

1. Bronchiectasis 100%
2. Pneumonia 47%
3. Anti-Bacterial Agents 27%
4. Bacterial Load 21%
5. Atorvastatin 17%
6. Respiratory Tract Infections 17%
7. Neutrophils 13%
8. Neutrophil Activation 13%
9. Sputum 13%
10. Mannose-Binding Lectin 12%
11. Thorax 12%
12. Mannose-Binding Protein Deficiency 12%
13. Leukotriene A4 12%
14. Mannose-Binding Lectin Complement Pathway 11%
15. Hospitalization 11%
16. Cough 11%
17. lipoxin A4 11%
18. Cohort Studies 11%
19. Prospective Studies 11%
20. Randomized Controlled Trials 11%
21. Therapeutics 11%
22. Pseudomonas aeruginosa 11%
23. Meta-Analysis 10%
24. Fibrosis 10%
25. Systematic Reviews 10%
26. ficolin 10%
27. Deficiency Diseases 10%
28. Mycoplasma Pneumonia 10%
29. Multiplex Polymerase Chain Reaction 9%
30. Lipid A 9%
31. Inflammation 9%
32. Mortality 9%
33. Clostridium Infections 9%
34. Proof of Concept Study 9%
35. Clarithromycin 8%
36. Drug Therapy 8%
37. Odds Ratio 8%
38. Scotland 8%
39. Macrolides 8%
40. Suction 8%
41. Mycoplasma pneumoniae 8%
42. Validation Studies 8%
43. Lung 8%
44. Interstitial Lung Diseases 7%
45. Pneumothorax 7%
46. Confidence Intervals 7%
47. Pulmonary Tuberculosis 7%
48. Gram-Negative Bacteria 7%
49. Microbiology 7%
50. Real-Time Polymerase Chain Reaction 6%